Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 16;7(1):33.
doi: 10.1038/s41537-021-00163-2.

Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity

Affiliations

Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity

Simon Fish et al. NPJ Schizophr. .

Abstract

Chronic cannabis use and schizophrenia are both thought to affect reward processing. While behavioural and neural effects on reward processing have been investigated in both conditions, their interaction has not been studied, although chronic cannabis use is common among these patients. In the present study eighty-nine participants divided into four groups (control chronic cannabis users and non-users; schizophrenia patient cannabis users and non-users) performed a two-choice decision task, preceded by monetary cues (high/low reward/punishment or neutral), while being scanned using functional magnetic resonance imaging. Reward and punishment anticipation resulted in activation of regions of interest including the thalamus, striatum, amygdala and insula. Chronic cannabis use and schizophrenia had opposing effects on reward anticipation sensitivity. More specifically control users and patient non-users showed faster behavioural responses and increased activity in anterior/posterior insula for high magnitude cues compared to control non-users and patient users. The same interaction pattern was observed in the activation of the right thalamus for reward versus punishment cues. This study provided evidence for interaction of chronic cannabis use and schizophrenia on reward processing and highlights the need for future research addressing the significance of this interaction for the pathophysiology of these conditions and its clinical consequences.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Reaction time (RT) differences between groups.
Mean RT difference (ms) for magnitude contrast for each group. ms milliseconds, HC−C non-cannabis user healthy controls, HC + C cannabis-user healthy controls, SZ−C non-cannabis user schizophrenia patients, SZ + C cannabis-user schizophrenia patients. Error bars indicate standard errors of the mean differences.
Fig. 2
Fig. 2. Validation analysis.
Clusters of higher activation for reward + punishment versus neutral conditions for the valence (a) and magnitude (b) cue period as well as high versus low + neutral for the magnitude cue period (c). Clusters thresholded at p < 0.005 for visualisation purposes. Red = thalamus; green = caudate; cyan = nucleus accumbens; peach = amygdala; brown = dorsal anterior insula; yellow = ventral anterior insula.
Fig. 3
Fig. 3. Main analysis.
Clusters showing significant modulation by the interaction of cannabis and schizophrenia for the reward versus punishment contrast (a) and the magnitude contrast (b). Clusters thresholded at p < 0.005 for visualisation purposes. Red = thalamus; yellow = ventral anterior insula; brown = dorsal anterior insula; violet = posterior insula. The bar plots show mean beta values for each cluster for each group and error bars show standard errors of the mean beta values. HC−C non-cannabis user healthy controls, HC + C cannabis-user healthy controls, SZ−C non-cannabis user schizophrenia patients, SZ + C cannabis-user schizophrenia patients.

Similar articles

Cited by

References

    1. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Bmj. 2002;325:1199. doi: 10.1136/bmj.325.7374.1199. - DOI - PMC - PubMed
    1. Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bull. 2016;42:1262–1269. doi: 10.1093/schbul/sbw003. - DOI - PMC - PubMed
    1. Di Forti M, et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophrenia Bull. 2014;40:1509–1517. doi: 10.1093/schbul/sbt181. - DOI - PMC - PubMed
    1. Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophrenia Bull. 2010;36:1115–1130. doi: 10.1093/schbul/sbp031. - DOI - PMC - PubMed
    1. Sami MB, Bhattacharyya S. Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders. J. Psychopharmacol. 2018;32:825–849. doi: 10.1177/0269881118760662. - DOI - PMC - PubMed